A Model for Responding to Chemotherapy Infusion Hypersensitivity Reactions
Hypersensitivity treatment algorithms and standing orders provide the nurse with the opportunity to feel confident in their ability to manage hypersensitivity and enable them to intervene earlier. Early intervention may lead to better outcomes for the patient and the potential for completion of treatments versus changes to the treatment plan.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Management of Colorectal Cancer
Continued education on the advancements of colorectal cancer will help bridge knowledge gaps and improve the quality of care offered to patients.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Bispecific Antibodies: A New Frontier in Immunotherapy
The advances in immunotherapy in cancer care are ever-changing and complex. It is integral for nurses to have current knowledge of bispecific antibody therapies in hematologic malignancies and to understand their mechanisms of action and side effect profiles to support optimal patient outcomes.
Category
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Pain Management in Oncology
Pain management is a crucial component of patient-centered care, particularly in oncology. Since there are many modalities to treat cancer-related pain, education on commonly utilized strategies and pharmacologic agents will be beneficial to improving patient care.
Category
  • Pain
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Current Treatment Approaches for Transformed Indolent B-Cell Lymphomas
Education about the recent advances and special considerations associated with the diagnosis and management of transformed indolent lymphomas is essential to facilitate the incorporation of novel treatment options into routine clinical practice to improve clinical outcomes.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Updates on Safe Handling
Continued education on this topic and staying informed on the most up-to-date information will always be necessary to improve the overall safety of oncology nursing professionals.
Category
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Updates in the Management of Neuroblastoma
Neuroblastoma is a complex pediatric cancer that can be challenging to treat. It is important to be informed of the updated risk classification system for stratifying those with neuroblastoma, as well as the recommended treatment strategies for each risk group, to ensure optimal outcomes for patients.
Category
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Updates in Clinical Management of Pancreatic Cancer
Recent studies delineating molecular alterations in pancreatic cancer and germline alterations in individuals with pancreatic cancer highlight the need to understand the changing landscape of clinical tools available for diagnosing and treating this cancer effectively.
Category
  • Pancreatic Cancer
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Updates to Treatment of Recurrent/Metastatic Head and Neck Cancers
For patients with widely metastatic head and neck cancer, the goal is palliation or prolongation of life. Recent studies show that immunotherapy provides a reasonable treatment option for patients with recurrent or metastatic squamous cell carcinoma of the head and neck. This presentation will discuss new and emerging treatment options to optimize outcomes for these patients.
Category
  • Head and Neck Cancers
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
Updates in the Management of Small Cell Lung Cancer
For many years, platinum plus etoposide regimens had been recommended for patients with extensive stage small cell lung cancer (SCLC); however, the preferred regimens for extensive stage SCLC now include immune checkpoint inhibitors, either atezolizumab or durvalumab, plus platinum plus etoposide.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation

Pages